Document is current

Any future updates will be listed below

FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab

Crossref DOI link: https://doi.org/10.1186/1471-2407-14-340

Published Online: 2014-05-19

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark